Results 11 to 20 of about 2,228 (187)

Schizophrenia in a case of alopecia universalis [PDF]

open access: yesAnnals of Indian Psychiatry, 2017
Alopecia universalis is characterized by total loss of hair from all over the body such as the scalp, eyebrows, and limbs. Alopecia areata has been known to coexist with psychiatric disorders such as anxiety disorders and depression, although reports ...
Deepa Sangolkar   +4 more
doaj   +3 more sources

Unexpected hair regrowth in a woman with longstanding Alopecia universalis [PDF]

open access: yesGMS Ophthalmology Cases, 2021
Alopecia areata (AA) is an autoimmune disorder leading to non-scarring hair loss. As long as hair follicles are not destroyed, the potential for hair regrowth remains.
Akritidou, Fani   +4 more
doaj   +4 more sources

Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report [PDF]

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Leah A Johnston   +2 more
doaj   +3 more sources

Successful treatment of alopecia universalis with abrocitinib: a case report [PDF]

open access: yesJournal of Dermatological Treatment, 2023
Abrocitinib, a highly selective inhibitor of Janus kinase 1 (JAK1), has been approved for the treatment of moderate-to-severe atopic dermatitis (AD).
Yagang Zuo
exaly   +3 more sources

Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report [PDF]

open access: yesIDCases, 2023
Messenger RNA vaccines against SARS-CoV-2 infection, or COVID-19 dramatically changed the landscape of the fight against COVID-19 pandemic. However, they might be associated with various side effects, such as myocarditis.
Kentaro Iwata, Makoto Kunisada
doaj   +4 more sources

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis [PDF]

open access: yesCase Reports in Dermatology, 2016
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes surround the basis of the follicles, inducing loss of pigmented terminal hair and subsequently inhibit further hair growth.
Florian Anzengruber   +5 more
doaj   +9 more sources

Alopecia universalis, renal stones, and hyperuricemia: A familial or an unfamiliar association [PDF]

open access: yesJournal of Family Medicine and Primary Care, 2014
Alopecia Universalis is an autoimmune disorder which sometimes may be associated with other autoimmune diseases like vitiligo, atopic dermatitis and endocrine disorders like hypothyroidism.
Kalachand Jana   +4 more
doaj   +2 more sources

Drug Reaction with eosinophilia and systemic symptoms with alopecia universalis and vitiligo [PDF]

open access: yesMedicina, 2021
Drug reactions with eosinophilia and systemic symptoms (DRESS) are rare and potentially fatal adverse hypersensitivity reaction to some drugs, especially anticonvulsants. The syndrome affects not only the skin but also other organs, especially the liver.
Ives Alexandre Yutani Koseki   +5 more
doaj   +3 more sources

Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis [PDF]

open access: yesFrontiers in Medicine
BackgroundAlopecia areata (AA) is a chronic immune-mediated disorder causing non-scarring hair loss. Severe forms like alopecia totalis (AT) and alopecia universalis (AU) pose therapeutic difficult situations.
Taiyo Hitaka   +6 more
doaj   +2 more sources

Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient [PDF]

open access: yesJournal of Allergy and Clinical Immunology: Global
A 29-year-old male patient had severe atopic dermatitis (AD) and alopecia universalis (AU) that could not be controlled by using classic therapy. He started taking upadacitinib and achieved an excellent response for both his AD and AU. Thus, upadacitinib
Mara Giavina-Bianchi, MD, PhD   +1 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy